|
1
|
Hao H, Zhou Z, Li S, Maquilan G, Folkert
MR, Iyengar P, Westover KD, Albuquerque K, Liu F, Choy H, et al:
Shell feature: A new radiomics descriptor for predicting distant
failure after radiotherapy in non-small cell lung cancer and cervix
cancer. Phys Med Biol. 63:0950072018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reck M and Rabe KF: Precision Diagnosis
and Treatment for Advanced Non-Small-Cell Lung Cancer. N Engl J
Med. 377:849–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tian H, Zhou C, Yang J, Li J and Gong Z:
Long and short noncoding RNAs in lung cancer precision medicine:
Opportunities and challenges. Tumour Biol. 39:10104283176975782017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tian Y, Zhang N, Chen S, Ma Y and Liu Y:
The long non-coding RNA LSINCT5 promotes malignancy in non-small
cell lung cancer by stabilizing HMGA2. Cell Cycle. 17:1188–1198.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang H, Kanmangne D, Li R, Qian Z, Xia X,
Wang X and Wang T: miR 30a 3p suppresses the proliferation and
migration of lung adenocarcinoma cells by downregulating CNPY2.
Oncol Rep. 43:646–654. 2020.PubMed/NCBI
|
|
6
|
Tang XD, Zhang DD, Jia L, Ji W and Zhao
YS: lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small
Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor
Signaling Pathway. Cell Physiol Biochem. 50:179–195. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qian H, Chen L, Huang J, Wang X, Ma S, Cui
F, Luo L, Ling L, Luo K and Zheng G: The lncRNA MIR4435-2HG
promotes lung cancer progression by activating β-catenin
signalling. J Mol Med (Berl). 96:753–764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Santosh B, Varshney A and Yadava PK:
Non-coding RNAs: Biological functions and applications. Cell
Biochem Funct. 33:14–22. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kunej T, Obsteter J, Pogacar Z, Horvat S
and Calin GA: The decalog of long non-coding RNA involvement in
cancer diagnosis and monitoring. Crit Rev Clin Lab Sci. 51:344–357.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun J, Zhang Y, Li B, Dong Y, Sun C, Zhang
F, Jin L, Chen D and Wang W: PITPNA-AS1 abrogates the inhibition of
miR-876-5p on WNT5A to facilitate hepatocellular carcinoma
progression. Cell Death Dis. 10:8442019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Q, Li L, Bo Q, Chen L, Sun L and Shi
H: Long noncoding RNA PITPNA-AS1 promotes cervical cancer
progression through regulating the cell cycle and apoptosis by
targeting the miR-876-5p/c-MET axis. Biomed Pharmacother.
128:1100722020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lv W, Wang J and Zhang S: Effects of
cisatracurium on epithelial-to-mesenchymal transition in esophageal
squamous cell carcinoma. Oncol Lett. 18:5325–5331. 2019.PubMed/NCBI
|
|
15
|
Ding NH, Zhang L, Xiao Z, Rong ZX, Li Z,
He J, Chen L, Ou DM, Liao WH and Sun LQ: NEK4 kinase regulates EMT
to promote lung cancer metastasis. J Cell Mol Med. 22:5877–5887.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yeh IJ, Liu KT, Shen JH, Wu YH, Liu YH,
Yen MC and Kuo PL: Identification of the Potential Prognostic
Markers from the miRNA-lncRNA-mRNA Interactions for Metastatic
Renal Cancer via Next-Generation Sequencing and Bioinformatics.
Diagnostics (Basel). 10:2282020. View Article : Google Scholar
|
|
17
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Jin C, Yang G, Wang B, Hua P and
Zhang Y: lncRNA WTAPP1 promotes cancer cell invasion and migration
in NSCLC by downregulating lncRNA HAND2-AS1. BMC Pulm Med.
20:1532020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen QF, Kong JL, Zou SC, Gao H, Wang F,
Qin SM and Wang W: lncRNA LINC00342 regulated cell growth and
metastasis in non-small cell lung cancer via targeting miR-203a-3p.
Eur Rev Med Pharmacol Sci. 23:7408–7418. 2019.PubMed/NCBI
|
|
21
|
Ombrato L and Malanchi I: The EMT
universe: Space between cancer cell dissemination and metastasis
initiation. Crit Rev Oncog. 19:349–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qian B, Wang X, Mao C, Jiang Y, Shi Y,
Chen L, Liu S, Wang B, Pan S, Tao Y, et al: Long non-coding RNA
linc01433 promotes migration and invasion in non-small cell lung
cancer. Thorac Cancer. 9:589–597. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen JH, Zhou LY, Xu S, Zheng YL, Wan YF
and Hu CP: Overexpression of lncRNA HOXA11-AS promotes cell
epithelial-mesenchymal transition by repressing miR-200b in
non-small cell lung cancer. Cancer Cell Int. 17:642017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao YP, Li Y, Li HJ and Zhao B: lncRNA
NBR2 inhibits EMT progression by regulating Notch1 pathway in
NSCLC. Eur Rev Med Pharmacol Sci. 23:7950–7958. 2019.PubMed/NCBI
|
|
25
|
Yu DJ, Li YH and Zhong M: lncRNA
FBXL19-AS1 promotes proliferation and metastasis via regulating
epithelial-mesenchymal transition in non-small cell lung cancer.
Eur Rev Med Pharmacol Sci. 23:4800–4806. 2019.PubMed/NCBI
|
|
26
|
Ji X, Tao R, Sun LY, Xu XL and Ling W:
Down-regulation of long non-coding RNA DUXAP8 suppresses
proliferation, metastasis and EMT by modulating miR-498 through
TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer. Eur
Rev Med Pharmacol Sci. 24:3152–3165. 2020.PubMed/NCBI
|
|
27
|
Pan JC, Meng XD and Gong ZH: The Role of
lncRNA as Competitive Endogenous RNA in Non-Small Cell Lung
Cancers. Prog. Biochem. Biophys. 45:1126–1135. 2018.
|
|
28
|
Jia YC, Wang JY, Liu YY, Li B, Guo H and
Zang AM: lncRNA MAFG-AS1 facilitates the migration and invasion of
NSCLC cell via sponging miR-339-5p from MMP15. Cell Biol Int.
43:384–393. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu YJ, Zhou HG, Chen LH, Qu DC, Wang CJ,
Xia ZY and Zheng JH: miR-32-5p regulates the proliferation and
metastasis of cervical cancer cells by targeting HOXB8. Eur Rev Med
Pharmacol Sci. 23:87–95. 2019.PubMed/NCBI
|
|
30
|
Liang H, Tang Y, Zhang H and Zhang C:
miR-32-5p regulates radiosensitization, migration and invasion of
colorectal cancer cells by targeting TOB1 gene. OncoTargets Ther.
12:9651–9661. 2019. View Article : Google Scholar
|
|
31
|
Wang M, Sun Y, Xu J, Lu J, Wang K, Yang
DR, Yang G, Li G and Chang C: Preclinical studies using miR-32-5p
to suppress clear cell renal cell carcinoma metastasis via altering
the miR-32-5p/TR4/HGF/Met signaling. Int J Cancer. 143:100–112.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ye T, Zhang N, Wu W, Yang B, Wang J, Huang
W and Tang D: SNHG14 promotes the tumorigenesis and metastasis of
colorectal cancer through miR-32-5p/SKIL axis. In Vitro Cell Dev
Biol Anim. 55:812–820. 2019. View Article : Google Scholar : PubMed/NCBI
|
